Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study

Saved in:
Bibliographic Details
Main Authors: Mihir Gharia, A Sudhakar
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:Indian Journal of Rheumatology
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=2;spage=151;epage=152;aulast=Gharia
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561311896403968
author Mihir Gharia
A Sudhakar
author_facet Mihir Gharia
A Sudhakar
author_sort Mihir Gharia
collection DOAJ
format Article
id doaj-art-14fd4c0d766f4599a3cf02a578e70046
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2019-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-14fd4c0d766f4599a3cf02a578e700462025-01-03T01:45:59ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012019-01-0114215115210.4103/injr.injr_154_18Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational StudyMihir GhariaA Sudhakarhttp://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=2;spage=151;epage=152;aulast=Gharia
spellingShingle Mihir Gharia
A Sudhakar
Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study
Indian Journal of Rheumatology
title Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study
title_full Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study
title_fullStr Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study
title_full_unstemmed Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study
title_short Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study
title_sort reduced injection site pain with succinate buffer based adalimumab biosimilar zrc 3197 injection suffer study an observational study
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=2;spage=151;epage=152;aulast=Gharia
work_keys_str_mv AT mihirgharia reducedinjectionsitepainwithsuccinatebufferbasedadalimumabbiosimilarzrc3197injectionsufferstudyanobservationalstudy
AT asudhakar reducedinjectionsitepainwithsuccinatebufferbasedadalimumabbiosimilarzrc3197injectionsufferstudyanobservationalstudy